NCT03963180

Brief Summary

Minimally invasive surgery (MIS) has revolutionized women's healthcare. Laparoscopy is an excellent route of MIS. Today, laparoscopic surgery is one of the major procedure in the management of a gynecologic disease. It has revealed benefits of decreased morbidity, earlier discharged, and quicker return to normal daily activities, and shorter hospital when compared to abdominal approach. Postoperative ileus (POI) defined as an uncomplicated ileus occurring following surgery, resolving spontaneously within 2 to 3 days. Clinically, it is characterized by abdominal distension, a lack of bowel sounds, nausea, vomiting, stomach cramps, and lack of flatus. It leads to morbidity and delays in patient discharge from the hospital, leading to an increased economic burden on the healthcare system. That's why many researchers have focused on the prevent of postoperative ileus; many studies have investigated preventive approaches such as early mobilization of the patient, adequate pain control, epidural anaesthesia, hot pack therapy, motility agents such as metoclopramide, and alvimopan. Although POI incidence has lower after the laparoscopic surgery it remains a major problem during the postoperative period. Recent studies demonstrated that coffee consumption is associated with improved gastrointestinal function without worsening of postoperative morbidity for both open and laparoscopic surgery. However, until now, no studies investigating the effect of postoperative coffee consumption at laparoscopic gynecologic surgery. Therefore, the investigators performed a randomized controlled trial to assess whether coffee consumption accelerates the recovery of bowel function after laparoscopic gynecologic surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 19, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 24, 2019

Completed
3 days until next milestone

Study Start

First participant enrolled

May 27, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

March 27, 2020

Status Verified

March 1, 2020

Enrollment Period

7 months

First QC Date

May 19, 2019

Last Update Submit

March 26, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time to first passage of flatus

    Patients were checked hourly by auscultation for bowel sounds and were asked to note the time of first flatus and defecation and to inform the observing nurses or assistant.The time to the first passage of flatus after surgery during routine postoperative care.

    72 hours

Secondary Outcomes (2)

  • Time to tolerance of a solid diet

    72 hours

  • Time to the first bowel movement

    72 hours

Study Arms (2)

control group

NO INTERVENTION

the control group received 3 cups hot water on the 6th, 12th and 18th hours after the operation

study group

EXPERIMENTAL

drank 3 cups of caffeinated coffee on the 6th, 12th and 18th hours after the operation.

Other: coffee

Interventions

coffeeOTHER

All patients were asked to drink the entire 150-mL amounts within 20 minutes under the supervision of a nurse or doctor. Patients were free to drink any amount of water but no more coffee, black tea, or other forms of caffeine, such as soda. Coffee and hot water were prepared with a conventional coffee machine (Nescafe Alegria; 100 g caffeine; Nestlé. Gatwick, United Kingdom).

study group

Eligibility Criteria

Age21 Years - 80 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients underwent total laparoscopic hysterectomy with or without additional surgery \*salpingo-oophorectomy,
  • salpingectomy,
  • pelvic and/or para-aortic lymphadenectomy

You may not qualify if:

  • patients with hypersensitivity or allergy to caffeine/ coffee,
  • patients with thyroid disease,
  • patients with inflammatory bowel disease,
  • patients with compromised liver function,
  • patients with clinically significant cardiac arrhythmia,
  • patients with chronic constipation (defined as \< 2 bowel movements per week),
  • patients with a history of abdominal bowel surgery,
  • patients with previous abdominal irradiation,
  • the requirement for postoperative care in the intensive care unit \>24 hours postoperatively,
  • the requirement for nasogastric tube drainage beyond the end of the surgery
  • requirement bowel anastomosis
  • conversion to laparotomy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Kemal Gungorduk

Muğla, 35460, Turkey (Türkiye)

Location

Mugla Sıtkı Kocman University Education and Research Hospital

Muğla, 48000, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Coffee

Intervention Hierarchy (Ancestors)

Plant PreparationsBiological ProductsComplex MixturesBeveragesDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 19, 2019

First Posted

May 24, 2019

Study Start

May 27, 2019

Primary Completion

December 31, 2019

Study Completion

December 31, 2019

Last Updated

March 27, 2020

Record last verified: 2020-03

Locations